Kedrion Biopharma: Your Committed Partner in Rabies Prevention

An investigational study of over 100,000 patients highlighted the challenges of administering post-exposure prophylaxis (PEP), and specifically human rabies immune globulin (HRIG), in children.¹

Rabies and Children: Prevalence and Challenges of HRIG Administration

Reference: 1. Burke RV, Russo P, Sicilia M, et al. Epidemiology of rabies immune globulin use in paediatric and adult patients in the USA: a cross-sectional prevalence study. BMJ Open. 2022;12:e055411. doi:10.1136/bmjopen-2021-055411